Karuna Therapeutics Inc (KRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Operating Expenses | 34,531 | 29,963 | 24,407 | 19,529 | 17,825 |
| Operating Income | -34,531 | -29,963 | -24,407 | -19,529 | -17,825 |
| Other Income | 115 | -534 | 441 | 688 | 779 |
| Pre-tax Income | -34,416 | -30,497 | -23,966 | -18,841 | -17,046 |
| Net Income Continuous | -34,416 | -30,497 | -24,009 | -18,841 | -17,046 |
| Net Income | $-34,416 | $-30,497 | $-24,009 | $-18,841 | $-17,046 |
| EPS Basic Total Ops | -1.17 | -1.10 | -0.90 | -0.71 | -0.65 |
| EPS Basic Continuous Ops | -1.17 | -1.10 | -0.90 | -0.71 | -0.65 |
| EPS Diluted Total Ops | -1.17 | -1.10 | -0.90 | -0.71 | -0.65 |
| EPS Diluted Continuous Ops | -1.17 | -1.10 | -0.90 | -0.71 | -0.65 |
| EBITDA(a) | $-34,277 | $-29,630 | $-23,983 | $-19,303 | $-17,825 |